Dabur scouts 2-3 acquisition targets, eyes up to two deals in three years
Dabur India is evaluating 2-3 acquisition targets, including D2C brands, and plans to acquire one or two sizable companies over the next three years. The FMCG major reported June-quarter net profit of ₹591 crore, up 15% year-on-year, on revenue of ₹3,764.4 crore.
What happened
Dabur India is evaluating 2-3 acquisition targets, including D2C brands, and aims to buy one or two sizable companies within three years. Its June-quarter
Key facts
- Consolidated net profit: ₹591 crore, up 15% year-on-year
- Consolidated revenue from operations: ₹3,764.4 crore, up 10.6% year-on-year
- Dabur Ventures allocation: about ₹500 crore
- Potential acquisition targets under discussion: 2-3 companies
- Planned acquisitions: 1-2 companies over three years
- India FMCG growth: 9.5%
- Underlying volume growth: 5%
- New products' revenue contribution: 2.6%
- Rain deficit: 14-15%
Why this matters
Dabur’s shift from venture investing to a defined pipeline of two or three targets creates a clear window for sizable D2C and adjacent FMCG brands seeking a strategic buyer.
What to watch
- Announcement of a controlling stake, rather than a minority venture investment, in a D2C or adjacent FMCG brand.
- Management commentary on acquisition budget, target revenue scale, category preferences or willingness to acquire unprofitable growth brands.
- Dabur Ventures portfolio companies raising capital, seeking strategic partners or showing accelerated offline expansion.
- Changes in Dabur's cash position, debt usage, treasury investments or board approvals for acquisition-related spending.
- Evidence that acquired or partner brands enter Dabur's distributor network, pharmacies or modern retail channels.
- Competitive M&A activity by HUL, Marico, ITC, Tata Consumer, Emami and other FMCG buyers that raises target valuations.
- Increase diligence on D2C brands with repeat purchase, positive contribution margins and differentiated formulations in wellness, nutrition, beauty and personal care.
- Seek targets whose online-led customer base can be expanded through Dabur's general trade, modern trade and pharmacy distribution.
- Structure transactions with staggered ownership, founder earn-outs and performance-linked payouts to manage valuation risk.
- Use Dabur Ventures investments as a proprietary sourcing funnel and potential path to majority acquisitions.
- Prepare post-deal integration playbooks focused on preserving brand independence while consolidating manufacturing, procurement, regulatory, distribution and back-office functions.